Three-dimensional models: a novel approach for lymphoma research Maura RossiFrancesco AlvianoClaudio Agostinelli Review – Cancer Research 29 January 2022 Pages: 753 - 765
Targeting PGC1α to wrestle cancer: a compelling therapeutic opportunity Xiangyu SunXiaoyan LiuYingying Xu Review – Cancer Research 15 January 2022 Pages: 767 - 774
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy S. Di CosimoC. DeprettoG. P. Scaperrotta Original Article – Cancer Research 17 January 2022 Pages: 775 - 781
Single-cell transcriptomic landscapes of a rare human laryngeal chondrosarcoma Chen LinZhisen ShenQi Ding Original Article – Cancer Research Open access 21 December 2021 Pages: 783 - 792
CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis Nádia Calvo Martins OkuyamaFernando Cezar-dos-SantosKaren Brajão de Oliveira Original Article – Cancer Research 27 January 2022 Pages: 793 - 802
Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer Yutuan WuNicholas B. JenningsWei Hu Original Article – Cancer Research Open access 30 January 2022 Pages: 803 - 821
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique Maria Alessia ZerellaSamantha DicuonzoBarbara Alicja Jereczek-Fossa Original Article – Cancer Research 06 January 2022 Pages: 823 - 835
CD147 expression lacks prognostic relevance in esophageal cancer Natalie KüstersKatharina GruppNathaniel Melling Original Article – Cancer Research Open access 08 January 2022 Pages: 837 - 844
Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes Lingxu JiangLi YeHongyan Tong Original Article – Cancer Research 10 January 2022 Pages: 845 - 856
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors Sophie EngelhardtFelix BehlingJens Schittenhelm Original Article – Cancer Research Open access 11 January 2022 Pages: 857 - 866
Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer Ting-Ting YuXing-Chun PengTong-Fei Li Original Article – Cancer Research 08 January 2022 Pages: 867 - 879
Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review Yamei ChenYing JinMing Chen Review – Clinical Oncology 08 January 2022 Pages: 881 - 895
The effect of intervention versus watchful waiting on disease progression and overall survival in smoldering multiple myeloma: a systematic review of randomized controlled trials Ademola S. OjoSomtochukwu G. OjukwuRavi Sarma Review – Clinical Oncology 20 January 2022 Pages: 897 - 911
Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis Xiaozhe LiBeihui HuangJuan Li Original Article – Clinical Oncology 08 May 2021 Pages: 913 - 919
Clinical target volume design of postoperative intensity-modulated radiotherapy for major salivary gland tumours according to surgical principles: an innovative method Shaowen LyuZheng WuYong Su Original Article – Clinical Oncology 10 May 2021 Pages: 921 - 930
A novel classification of portal venous tumor invasion to predict residual tumor status after surgery in patients with pancreatic neuroendocrine neoplasms Tomotaka KatoAtsushi KudoMinoru Tanabe Original Article – Clinical Oncology 13 May 2021 Pages: 931 - 941
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China Guochao ZhangChaoqi ZhangJie He Original Article – Clinical Oncology 19 May 2021 Pages: 943 - 954
Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US) Dane WildnerLucie HeinzerlingFerdinand Knieling Original Article – Clinical Oncology Open access 28 May 2021 Pages: 955 - 965
Safety and efficacy of tomosynthesis-guided breast biopsies in the prone position: monocentric study and review of the literature Antonio CatelliAngela SantoroSalvatore Minelli Original Article – Clinical Oncology 30 May 2021 Pages: 967 - 974
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study V. LeclercL. KarlinF. Ranchon Original Article – Clinical Oncology 18 June 2021 Pages: 975 - 984
Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies Laura SchwenkSusan WittigBernd Gruhn Original Article – Clinical Oncology Open access 21 June 2021 Pages: 985 - 991
HER2 positivity as a biomarker for poor prognosis and unresponsiveness to anti-EGFR therapy in colorectal cancer Wenbai HuangYijiao ChenJianmin Xu Original Article – Clinical Oncology 22 June 2021 Pages: 993 - 1002
Response to letter to the editor regarding C Franzese et al. “Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer” Ciro FranzeseAusilia TeriacaMarta Scorsetti Letter to the Editor 16 September 2021 Pages: 1003 - 1004
A novel 3’ truncated ALK cause ALK + in a patient with minimally invasive adenocarcinoma Jian ChenZhaonan YuYue Wang Letter to the Editor 08 October 2021 Pages: 1005 - 1006
Correction to: SOX2 inhibits metastasis in gastric cancer Yansu ChenYefei HuangJianwei Zhou Correction 22 December 2021 Pages: 1007 - 1009
